Dominik Rüttinger

Years Active: 2020-2021
Publications (10 Years): 2

Roche Diagnostics GmbH

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roche Diagnostics GmbH Apr 1o 2011

Germany

Global Head Early Clinical Development Oncology :: pRED Early Clinical Development Oncology

Publications

Jürgen Wichmann, Caroline Rynn, Thomas Friess, Jeannine Petrig-Schaffland, Martin Kornacker, Cornelia Handl, Jasmin Emmenegger, Jan Eckmann, Frank Herting, Nicolas Frances, Daniel Hunziker, Daniela Krummenacher, Dominik Rüttinger, Alison Ribeiro, Marina Bacac, Alessandro Brigo, David S Hewings, Reinhard Dummer, Mitchell P Levesque, Gabriel Schnetzler, Bruno Martoglio, James R Bischoff, Piergiorgio Pettazzoni
Preclinical characterization of a next generation brain permeable, paradox breaker BRAF inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Christoph M Griessinger, Tove Olafsen, Alessandro Mascioni, Ziyue Karen Jiang, Charles Zamilpa, Fang Jia, Michael Torgov, Jason M Romero, Filippo Marchioni, Daulet Satpayev, Chenyu Lee, Green Zhang, Tapan K Nayak, Mudita Pincha, Maria Amann, Preethi L B Mohan, Marine Richard, Valeria G Nicolini, Johannes Sam, Christina Claus, Claudia Ferrara, Peter Brünker, Marina Bacac, Pablo Umana, Dominik Rüttinger, Ian A Wilson, Jean Gudas, Christiane Neumann, Jean J L Tessier
The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment. Cancer research 80 (13) (2020)

Dominik Rüttinger.css-eqlu8i{font-size:small;padding-left:4px;}